ANNOUNCEMENT FROM VTESSE
VTESSE Medicines and Healthcare Products Regulatory Agency (“MHRA”) Designates VTS-270 as a...
VTESSE Medicines and Healthcare Products Regulatory Agency (“MHRA”) Designates VTS-270 as a...
AIDNPC CLINICAL PROGRAMME UPDATE: Orphazyme Expands NPC Study to Three Sites in the USA Full Press...
AIDNPC CLINICAL PROGRAMME UPDATE: Orphazyme announces update to its Niemann-Pick Disease Type C Clinical...
The NNPDF Central Office has received the following announcement from the Quinn Madeleine Foundation: . The...
RECEIVED FROM THE NIH Gene therapy shows promise for treating Niemann-Pick disease type C1 NIH mouse study...
The NNPDF Central Office has received a research request for ASMD (NPA/NPB) that has been approved by...